Technology

Global Selective Cox-2 Inhibitors Market Insights and Forecast to 2028

Selective Cox-2 Inhibitors market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Selective Cox-2 Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Download FREE Sample of this Report @ https://www.statsmarketresearch.com/download-free-sample/7106910/global-selective-cox-inhibitors-2028-690

 

    • Meloxicam

 

    • Celecoxib

 

    • Etoricoxib

 

    • Imrecoxib

 

    • Etodolac

 

    • Parecoxib

 

    • Other

 

Segment by Application

 

    • Rheumatoid Arthritis

 

    • Osteoarthritis

 

    • Spondylosis Chronica Ankylopoietica

 

    • Other

 

By Company

 

    • Boehringer-Ingelheim

 

    • TerSera Therapeutics

 

    • Iroko Pharmaceuticals

 

    • Apotex

 

    • Yung Shin Pharmaceutical

 

    • Breckenridge Pharmaceutical

 

    • Meda Pharmaceuticals

 

    • Cipla

 

    • Glenmark Pharmaceuticals

 

    • Teva

 

    • PuraCap Pharmaceutical

 

    • Almirall Limited

 

    • Lupin Pharmaceuticals

 

    • Aurobindo Pharma

 

    • Pfizer

 

    • Mylan

 

    • Takeda

 

    • Bayer

 

    • Novacap

 

    • Abbott

 

    • Geri-Care

 

    • Perrigo

 

    • Kopran

 

    • Merck

 

    • Hengrui pharmaceutical

 

    • Kelun Group

 

    • Qilu Pharmaceutical

 

    • Taro Pharmaceuticals

 

By Region

 

    • North America

 

    • United States

 

    • Canada

 

    • Europe

 

    • Germany

 

    • France

 

    • UK

 

    • Italy

 

    • Russia

 

    • Nordic Countries

 

    • Rest of Europe

 

    • Asia-Pacific

 

    • China

 

    • Japan

 

    • South Korea

 

    • Southeast Asia

 

    • India

 

    • Australia

 

    • Rest of Asia

 

    • Latin America

 

    • Mexico

 

    • Brazil

 

    • Rest of Latin America

 

    • Middle East & Africa

 

    • Turkey

 

    • Saudi Arabia

 

    • UAE

 

    • Rest of MEA

 

 

Table of content

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Selective Cox-2 Inhibitors Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Meloxicam
1.2.3 Celecoxib
1.2.4 Etoricoxib
1.2.5 Imrecoxib
1.2.6 Etodolac
1.2.7 Parecoxib
1.2.8 Other
1.3 Market by Application
1.3.1 Global Selective Cox-2 Inhibitors Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Rheumatoid Arthritis
1.3.3 Osteoarthritis
1.3.4 Spondylosis Chronica Ankylopoietica
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Selective Cox-2 Inhibitors Market Perspective (2017-2028)
2.2 Selective Cox-2 Inhibitors Growth Trends by Region
2.2.1 Selective Cox-2 Inhibitors Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Selective Cox-2 Inhibitors Historic Market Size by Region (2017-2022)
2.2.3 Selective Cox-2 Inhibitors Forecasted Market Size by Region (2023-2028)
2.3 Selective Cox-2 Inhibitors Market Dynamics
2.3.1 Selective Cox-2 Inhibitors Industry Trends
2.3.2 Selective Cox-2 Inhibitors Market Drivers
2.3.3 Selective Cox-2 Inhibitors Market Challenges
2.3.4 Selective Cox-2 Inhibitors Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Selective Cox-2 Inhibitors Players by Revenue

CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170 / +91 8087042414

Related Articles

Back to top button